CALC CalciMedica, Inc.
CalciMedica, Inc. (CALC) is expected to report earnings on November 10, 2026, before the market open. The consensus earnings estimate is a loss of $0.15 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +2.3% since its last earnings release on August 11, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About CalciMedica, Inc.
CalciMedica Inc. is a clinical-stage biopharmaceutical company. It focused on developing therapies for life-threatening inflammatory diseases with high unmet need. CalciMedica Inc. is based in LA JOLLA, Calif.
Sector
Healthcare
Industry
Biotechnology